SOST and atherosclerosis: Findings that sclerostin is expressed in arterial tissue and acts as a wnt inhibitor, and that the wnt pathway plays a role in the trans-differentiation of vascular smooth muscle cell towards an osteoblastic/calcifying phenotype, provides circumstantial evidence that sclerostin produced in arterial tissue may provide a natural defence mechanism against atherosclerosis.